MSK | Jotup

Luna Named Among 2024's Most Innovative Healthcare Companies by Fast Company

Retrieved on:

Tuesday, April 2, 2024

Health, Risk, Patient, Health care, MSK, Uber, Artificial intelligence, Nursing

Recognized for its outstanding contributions to healthcare, Luna secured the #13 position in the Healthcare category, showcasing its commitment to revolutionizing patient care and physical therapy accessibility.

Key Points:

Recognized for its outstanding contributions to healthcare, Luna secured the #13 position in the Healthcare category, showcasing its commitment to revolutionizing patient care and physical therapy accessibility.
Luna’s innovative model combines the best of personalized at-home care with the convenience of technology.
According to Fast Company , “Luna, since its founding in 2018, has been committed to helping patients with MSK conditions and post-operative patients improve their conditions via in-home physical therapy appointments.
Luna also launched a dedicated Artificial Intelligence (AI) division named Luna Labs to enhance patient care, organized under the company’s Co-Founder, Chief Technology Officer, and former Uber engineer Ryan Gaffney.

Forbes Recognizes Luna as a Top-Rated Employer in its List of America’s Best Employers for 2024

Retrieved on:

Tuesday, March 26, 2024

Emory Healthcare, Growth, Therapy, Health, Patient, Social media, Adventist Health, Intermountain Health, Investment, MSK, McKinsey & Company, Nursing

Out of the 3,000 companies evaluated, Luna ranked #111 overall, tenth in healthcare, and first in musculoskeletal (MSK) care.

Key Points:

Out of the 3,000 companies evaluated, Luna ranked #111 overall, tenth in healthcare, and first in musculoskeletal (MSK) care.
“With Luna, practicing physical therapists can work on their schedules with patients in their communities, in their homes where care is accessible and more easily adhered to.
Luna blends expert physical therapy with convenience, offering personalized in-home care through licensed therapists via the Luna app .
To create the America’s Best Startup Employers list, Forbes identified 3,000 privately-held companies headquartered in the U.S. that employ more than 50 people and were founded between 2014 and 2021.

Mitchell Silberberg & Knupp Names First Director of DEI and Talent Development

Retrieved on:

Tuesday, March 26, 2024

Mitchell Silberberg & Knupp LLP is pleased to announce that the firm has appointed Iveliz Crespo as its first Director of DEI and Talent Development, reaffirming its dedication to advancing diversity, equity, and inclusion (DEI) within the legal profession.

Key Points:

Mitchell Silberberg & Knupp LLP is pleased to announce that the firm has appointed Iveliz Crespo as its first Director of DEI and Talent Development, reaffirming its dedication to advancing diversity, equity, and inclusion (DEI) within the legal profession.
View the full release here: https://www.businesswire.com/news/home/20240326334961/en/
Iveliz Crespo, Director of Diversity and Talent Development at Mitchell Silberberg & Knupp LLP (Photo: Business Wire)
“We are thrilled to welcome Iveliz to Mitchell Silberberg & Knupp as our first Director of DEI and Talent Development,” said Greg Hessinger, Chair of MSK.
Crespo will oversee the development and implementation of comprehensive DEI strategies, aimed at attracting, retaining, and advancing diverse talent within MSK.
“Mitchell Silberberg & Knupp has already displayed an impressive commitment to DEI both within the firm and to its clients,” said Crespo.

Biodesix Announces New Master Collaborative Research Agreement with Leading US Cancer Center

Retrieved on:

Monday, March 25, 2024

Science, Biotechnology, Research, Oncology, Health, Medical Devices, Health Technology, Genetics, PCR, Genomics, EVP, International, Biomarker, Cancer, Proteomics, MCRA, Bio-Rad Laboratories, MSRA, MSK

Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung diseases, today announced that it has entered into a new master collaborative research agreement (MCRA) with Memorial Sloan Kettering Cancer Center (MSK) under which the teams will collaborate on a development plan for diagnostic tests aimed at improving the treatment of cancer.

Key Points:

Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung diseases, today announced that it has entered into a new master collaborative research agreement (MCRA) with Memorial Sloan Kettering Cancer Center (MSK) under which the teams will collaborate on a development plan for diagnostic tests aimed at improving the treatment of cancer.
Biodesix will utilize its array of genomics, proteomics, and data mining capabilities with the aim of developing and commercializing oncology biomarker assays in collaboration with MSK .
“The expansion of our previous master sponsored research agreement (MSRA) into a master collaborative research agreement with MSK is a significant milestone for Biodesix and for biomarkers in oncology diagnostics.
Biodesix looks forward to co-developing and validating new test concepts under these agreements,” said Scott Hutton, CEO, Biodesix.

Net Health and ATA Examine Impact of Digital MSK on Rehab Therapy Practices with Six-Part Series

Retrieved on:

Wednesday, April 3, 2024

Editorial, DPT, Series, Organization, APTA, Innovation, Growth, Digital, Education, Patient, Health, Tablet, SVP, MBA, Potential, MSK, Ageing, Medical imaging

PITTSBURGH, April 3, 2024 /PRNewswire/ -- Net Health, a trusted source for specialized software solutions that empower restorative care providers across the continuum of care, today announced its Digital Musculoskeletal (MSK) thought leadership program titled, "Harnessing the Potential of Digital MSK Care," in cooperation with the American Physical Therapy Association (APTA). The series consists of on-demand webinars with leaders in the rehab therapy space and in-depth editorial created by Net Health, the APTA, and other subject matter experts, providing practical insight into how rehab therapy organizations can adopt digital tools as a part of their in-person practice. The series examines broader healthcare conversations and how they relate to digital MSK, such as consumerization and value-based care.

Key Points:

The series examines broader healthcare conversations and how they relate to digital MSK, such as consumerization and value-based care.
Digital MSK is a model for rehab therapy care delivery that leverages technologies and tools such as smartphones, tablets, apps, wearable technologies, and various other software solutions to support rehab therapy patients with musculoskeletal ailments.
The series serves as an educational platform for rehab therapy providers to learn about the impact of digital tools on their practices and how they can affect care, education, and business practices.
To learn more about Net Health and the future of digital MSK, visit www.Nethealth.com/dmsk

Viewpoint with Dennis Quaid Partners with Kinotek® to Explore Technological Innovation in Musculoskeletal Health

Retrieved on:

Wednesday, March 27, 2024

Health, Organization, Partnership, Knowledge, Musculoskeletal injury, 3D, Chronic pain, Quality of life, Human musculoskeletal system, Pain, Multimedia, MSK, Movement, Map, Television

MIAMI, March 27, 2024 /PRNewswire-PRWeb/ -- Viewpoint, the esteemed educational program hosted by actor Dennis Quaid, is thrilled to announce an upcoming collaboration with Kinotek for an episode dedicated to exploring technological innovation in musculoskeletal (MSK) health. This partnership underscores Viewpoint's commitment to providing viewers with informative and transformative content that highlights cutting-edge solutions to pressing health issues.

Key Points:

The educational program looks into the health sector...
MIAMI, March 27, 2024 /PRNewswire-PRWeb/ -- Viewpoint, the esteemed educational program hosted by actor Dennis Quaid, is thrilled to announce an upcoming collaboration with Kinotek for an episode dedicated to exploring technological innovation in musculoskeletal (MSK) health.
A representative of Viewpoint said, "We're excited to partner with Kinotek to explore the transformative potential of technology in musculoskeletal health.
As filming commences and preparations for distribution are underway, Viewpoint and Kinotek invite individuals and organizations to join the conversation and contribute to the ongoing dialogue surrounding musculoskeletal health and technological innovation.
Development Division, Viewpoint with host Dennis Quaid, 561-244-7620, [email protected] , www.viewpointproject.com
View original content to download multimedia: https://www.prweb.com/releases/viewpoint-with-dennis-quaid-partners-with...

Sworkit Health and Select Health Collaborate to Promote CDC's Physical Fitness Guidelines Among Health Plan Members and Intermountain Health Employees

Retrieved on:

Tuesday, March 26, 2024

Mindfulness, Reward, Health, Culture, Health promotion, Caregiver, Intermountain, Yoga, Intermountain Health, Pulse, Meditation, CDC, Physical fitness, Virgin Group, MSK

This relationship underscores a commitment to enhancing the health and well-being of Intermountain Health caregivers and Select Health members by promoting physical fitness and overall health outcomes.

Key Points:

This relationship underscores a commitment to enhancing the health and well-being of Intermountain Health caregivers and Select Health members by promoting physical fitness and overall health outcomes.
This initiative has led to a remarkable achievement: a 50% engagement rate among Intermountain Health employees, doubling the participation compared to non-incentivized programs.
"We are thrilled to collaborate with Intermountain Health and Select Health through the Virgin Pulse platform to support their employees and members in achieving their health and fitness goals.
"Our collaboration with Sworkit Health has sparked active involvement among our caregivers at Intermountain Health and our Select Health members, aligning with our mission of helping people live the healthiest lives possible," said Jeremy Drecksel, director of health promotion and wellness at Select Health.

Debbie's Dream Foundation: Curing Stomach Cancer Announce Groundbreaking Research Fellowship Grant for Gastric Cancer Research

Retrieved on:

Tuesday, March 19, 2024

Partnership, Education, Patient, Biomarker, Research, Helicobacter pylori, AACR, DRS, DDF, Stomach, MSK, Gastrointestinal cancer, Health, Stomach cancer, Pharmaceutical industry

FORT LAUDERDALE, Fla., March 19, 2024 /PRNewswire/ -- Debbie's Dream Foundation: Curing Stomach Cancer (DDF) announces an unprecedented collaboration with Memorial Sloan Kettering Cancer Center (MSK) that marks a significant leap forward in the field of gastric cancer research. Through the visionary efforts and support of DDF, a research fellowship grant has been established at MSK under the guidance of Dr. Yelena Janjigian, Chief of Gastrointestinal Oncology Service at MSK. The "Debbie's Dream Foundation Gastric Cancer Investigator" fellowship will focus on patient care, research, and education specifically for esophageal and gastric cancers. The collaboration is a testament to the shared commitment of DDF and MSK to fueling groundbreaking research and providing top-notch cancer care.

Key Points:

FORT LAUDERDALE, Fla., March 19, 2024 /PRNewswire/ -- Debbie's Dream Foundation: Curing Stomach Cancer (DDF) announces an unprecedented collaboration with Memorial Sloan Kettering Cancer Center (MSK) that marks a significant leap forward in the field of gastric cancer research.
The "Debbie's Dream Foundation Gastric Cancer Investigator" fellowship will focus on patient care, research, and education specifically for esophageal and gastric cancers.
The collaboration is a testament to the shared commitment of DDF and MSK to fueling groundbreaking research and providing top-notch cancer care.
Through the 'Debbie's Dream Foundation Gastric Cancer Investigator fellowship, we aim to make impactful strides in biomarker development, laboratory research, and translational studies in gastroesophageal cancer."

SOPHiA GENETICS Reports Fourth Quarter and Full Year 2023 Results

Retrieved on:

Tuesday, March 5, 2024

BOSTON and ROLLE, Switzerland, March 05, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today reported financial results for its fourth quarter and fiscal year ended December 31, 2023.

Key Points:

BOSTON and ROLLE, Switzerland, March 05, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today reported financial results for its fourth quarter and fiscal year ended December 31, 2023.
SOPHiA GENETICS will host a conference call and live webcast to discuss the fourth quarter and full year 2023 results, and financial guidance for the full year 2024 on Tuesday, March 5, 2024, at 8:00 a.m. (08:00) Eastern Time / 2:00 p.m. (14:00) Central European Time.
Additionally, an audio replay of the conference call will be available on the SOPHiA GENETICS website after its completion.
These non-IFRS measures are key measures used by SOPHiA GENETICS management and board of directors to evaluate its operating performance and generate future operating plans.

Stop & Shop Kicks Off 23rd Annual ‘Help Cure Childhood Cancer’ Campaign to Support MSK Kids, the Pediatric Program at Memorial Sloan Kettering Cancer Center

Retrieved on:

Friday, March 1, 2024

MSK, Doctor of Philosophy, MD, Physician, Hope, Stop & Shop, Stop, Health, Patient, Pediatrics, Child, Research, Partnership, Toy

NANUET, N.Y., March 01, 2024 (GLOBE NEWSWIRE) -- Today, Stop & Shop kicks off its annual ‘Help Cure Childhood Cancer’ campaign.

Key Points:

NANUET, N.Y., March 01, 2024 (GLOBE NEWSWIRE) -- Today, Stop & Shop kicks off its annual ‘Help Cure Childhood Cancer’ campaign.
From March 1 – March 31, Stop & Shop customers in the tri-state area will be able to support MSK Kids, the pediatric program at Memorial Sloan Kettering Cancer Center (MSK).
The annual fundraiser, which celebrates its 23rd anniversary this year, raises money to support pediatric cancer care, treatment, and research.
“Memorial Sloan Kettering Cancer Center and MSK Kids remain grateful for Stop & Shop’s steadfast commitment to pediatric cancer research and care,” said Andrew Kung, MD, PhD, Chair of the Department of Pediatrics at Memorial Sloan Kettering Cancer Center.